Tofacitinib Extended-Release Tablets 11 mg is a type of medicine that helps treat diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Tofacitinib is a medicine taken by mouth that helps to reduce swelling and make people feel better.
The long-lasting version of tofacitinib is made to be taken once a day, which makes it easier for patients. The pills are usually pink in color, shaped like ovals, and covered with a special coating that releases the medication slowly over time. The tablets have 11 mg of medicine in them.
How To Use Tofacitinib Extended-Release Tablets 11 mg
You must follow your doctor’s instructions when taking Tofacitinib Extended-Release Tablets 11 mg.
Usually, you take it once a day, whether you eat or not.
Take the tablet with water without crushing, chewing, or breaking it.
It’s very important to take your medicine at the same time every day to make sure there is always the same amount of medicine in your body.
Don’t take two doses if you missed one.
If you have any questions about how to use this medicine, talk to your doctor or pharmacist.
Benefits Of Tofacitinib Extended-Release Tablets 11 mg
The benefits of Tofacitinib Extended-Release Tablets 11 mg include:
Treatment of Rheumatoid Arthritis: Tofacitinib XR is a medicine that has been given the green light to help treat moderate to severe rheumatoid arthritis (RA) in grown-ups who haven’t had much success with methotrexate or other drugs used to modify the disease. It can make joints feel better and work better for people with RA.
Treatment of Psoriatic Arthritis: Tofacitinib XR is also permitted to be used for treating psoriatic arthritis (PsA) in adults who haven’t had success with other treatments. PsA is a long-lasting joint and skin condition that causes inflammation. Tofacitinib XR helps decrease joint pain and swelling, as well as improve skin problems caused by PsA.
Treatment of Ulcerative Colitis: Tofacitinib XR is for adults with moderate to severe ulcerative colitis (UC) that is not getting better with normal treatments. It helps make the problems of UC, like diarrhea, stomach ache, and bleeding in the rectum, better.
Convenient Once-Daily Dosing: Tofacitinib XR is a special version that lets you take it just once a day. This type of medicine lasts longer in the body and keeps the drug levels steady. It is more convenient for patients because they only need to take it once a day, while other types require multiple doses throughout the day.
Oral Administration: Tofacitinib XR comes in a tablet. You can swallow it, which is helpful for patients who prefer pills instead of shots
Side Effects Of Tofacitinib Extended-Release Tablets 11 mg
Common side effects include headache, diarrhea, nausea, and upper respiratory infections. More serious side effects may include an increased risk of infections, liver damage, and changes in blood cell counts.
Precautions Of Tofacitinib Extended-Release Tablets 11 mg
The precautions of Tofacitinib Extended-Release Tablets 11 mg include:
Infections: Tofacitinib may make you more likely to get serious infections, like infections that take advantage of weak immune systems and tuberculosis. Before beginning treatment, it is necessary to check for infections, like hepatitis B and C, and keep an eye out for any signs of infection during therapy.
Malignancies: Tofacitinib might make it more likely for someone to develop certain cancers, like lymphoma and other types of cancer. People who have had cancer in the past should be checked carefully before starting treatment.
Thrombosis: People who have had blood clots before or have a high chance of getting blood clots should be watched carefully during treatment.
Gastrointestinal Perforations: Patients who have had diverticulitis or other problems with their stomach and intestines should be watched carefully for signs that their stomach or intestines may have a hole in them.
Laboratory Monitoring: It is necessary to keep track of your health regularly and talk to your doctor about any unusual test results.
Pregnancy and Breastfeeding: Tofacitinib can be dangerous for a baby that is still growing inside the mother, so it is best to avoid taking it while pregnant unless the good things it might do outweigh the possible problems it could cause.